Several common drugs that contain valsartan, used to treat high blood pressure and heart failure, were recalled in the United States on Friday due to an "impurity" in the drug that poses a potential ...

Two pharmaceutical companies are expanding the recent recalls of a variety of blood pressure medications. All of the recalls are due to the finding of N-Methylnitrosobutyric acid above the acceptable ...

The US Food and Drug Administration has again expanded the list of recalled medications that contain valsartan, used as a component in a set of drugs to treat heart failure and blood pressure. The ...

A voluntary recall of a common drug used to control blood pressure and help prevent heart failure was announced by the U.S. Food and Drug Administration on Friday, a week after 22 other countries ...

The US Food and Drug Administration expanded the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure.

(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced Thursday the launch of Valsartan Tablets, USP, a therapeutic equivalent generic version of Diovan (valsartan) Tablets approved by the U.S.

A generic drug company has recalled three commonly prescribed blood pressure medications over concerns they could include small amounts of a cancer-causing impurity. The recalled drugs all include the ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr.

The new year brings a new blood pressure medication recall. This time Aurobindo Pharma USA has recalled 80 lots of its Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP and Valsartan ...

Amlodipine and Valsartan Tablets 10 mg/160 mg, 90-count bottles, lot No. 24x012, expiration 11/2018. Amlodipine and Valsartan Tablets 5 mg/320 mg, 90-count bottles, lot Nos. 25x028 and 25x029, ...

Since July 2018, there have been a string of recalls related to three common generic heart drugs — losartan, irbesartan and valsartan — due to the detection of probable human carcinogens. July 13, ...